M. Lavoie

发表

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome

J. Tardif, C. Berry, M. Guertin, 2017, PloS one.

Vascular protectants for the treatment of atherosclerosis

J. Tardif, J. Grégoire, P. L'Allier, 2003, Expert review of cardiovascular therapy.

Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational

R. McPherson, G. Fodor, J. Genest, 2009 .

Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies

J. Tardif, J. Grégoire, P. L'Allier, 2003, Current opinion in lipidology.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

R. Diaz, J. López-Sendón, J. Tardif, 2019, The New England journal of medicine.

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Manesh R. Patel, Neha J. Pagidipati, J. Stehli, 2020, The Lancet.

Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).

D. Gaudet, R. McPherson, G. Fodor, 2005, The Canadian journal of cardiology.

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Colin Berry, Marc-André Lavoie, Jean-Claude Tardif, 2007, JAMA.

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

J. Tardif, J. Pressacco, J. Grégoire, 2010, Circulation. Cardiovascular imaging.

Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C].

J. Genest, E. Heere‐Ress, J. Kastelein, 1999, Atherosclerosis.

Ezetimibe and cholesterol absorption.

M. Lavoie, 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

Glycaemic status influences the nature and severity of coronary artery disease

S. Lévesque, J. Tardif, C. Berry, 2010, Diabetologia.

Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.

S. Lévesque, J. Tardif, M. Guertin, 2006, The American journal of cardiology.

Intestinal cholesterol transport proteins: an update and beyond

E. Levy, D. Sinnett, M. Lambert, 2007, Current opinion in lipidology.

VAP: a versatile aggregate profiler for efficient genome-wide data representation and discovery

François Robert, Pierre-Étienne Jacques, Marc-André Lavoie, 2014, Nucleic Acids Res..

Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--observational.

R. McPherson, G. Fodor, J. Genest, 2009, Current medical research and opinion.

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.

Sara K. Rostanski, P. Teirstein, J. Bavaria, 2022, JAMA cardiology.

Differential elastic actuator for robotic interaction tasks

François Michaud, Marc-Antoine Legault, Michel Lauria, 2008, 2008 IEEE International Conference on Robotics and Automation.